We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

The Prevalence of Osteoporosis in Hemodialysis Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00308828
Recruitment Status : Completed
First Posted : March 30, 2006
Last Update Posted : June 6, 2008
Information provided by:
Papageorgiou General Hospital

Brief Summary:
The purpose of this study is to determine the prevalence and severity of osteoporosis in hemodialysis patients and to evaluate potential correlations with renal bone disease indices

Condition or disease Phase
Osteoporosis Phase 4

Study Type : Observational
Actual Enrollment : 166 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Prevalence of Osteoporosis in Hemodialysis Patients and Relevance With Renal Bone Disease
Study Start Date : January 2005
Primary Completion Date : August 2007
Study Completion Date : August 2007

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients on hemodialysis

Inclusion Criteria:

  • Chronic hemodialysis
  • Age > 18-year old

Exclusion Criteria:

  • Prior specific osteoporosis treatment except vitamin D and calcium supplement administration; active malignancy
  • Recent pregnancy
  • Immobilization

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00308828

Papageorgiou General Hospital
Thessaloniki, Greece, 56429
Sponsors and Collaborators
Papageorgiou General Hospital
Principal Investigator: Efstathios Mitsopoulos, MD Papageorgiou General Hospital

Responsible Party: Efstathios Mitsopoulos, Papageorgiou General Hospital, Thessaloniki, Greece
ClinicalTrials.gov Identifier: NCT00308828     History of Changes
Other Study ID Numbers: 47/31-1-2005
First Posted: March 30, 2006    Key Record Dates
Last Update Posted: June 6, 2008
Last Verified: June 2008

Additional relevant MeSH terms:
Bone Diseases, Metabolic
Bone Diseases
Musculoskeletal Diseases
Metabolic Diseases